TransCode sets 2025 annual meeting Aug 29; proposal deadline June 23

Transcode Therapeutics, Inc.

2025 Annual Meeting scheduled for August 29, 2025; record date July 11, 2025.
Stockholder proposals under Rule 14a-8 must be submitted by close of business on June 23, 2025.
Director nominations and other business also due by June 23, 2025 under universal proxy rules.
Meeting date is more than 30 days from June 13, 2024 annual meeting, triggering adjusted deadlines.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.